Autism and Asperger's syndrome

Current Opinion in Pediatrics

Volumn 9, Issue 4, 1997, Pages 361-366

  Towbin, Kenneth E ^a  

^a CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HALOPERIDOL; METHYLPHENIDATE; NALTREXONE;

ASPERGER SYNDROME; AUTISM; COGNITIVE DEFECT; DYSKINESIA; GENETICS; HUMAN; PRIORITY JOURNAL; REVIEW;

EID: 0030853585     PISSN: 10408703     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008480-199708000-00010     Document Type: Review

References (51)

1. Bryson SE: The epidemiology of autism. J Autism Dev Disord 1996, 26:165-169.
2. Wing L, Gould J: Severe impairment of social interaction and associated abnormalities in children: epidemiology and classification. J Autism Dev Disord 1979, 9:11-29
3. Hagberg B: Clinical stages, and natural history. Clinics in Developmental Medicine 1993, 127:4-21.
4. Volkmar FR: Childhood disintegrative disorder: issues for DSM-IV. J Autism Dev Disord 1992, 22:625-642.
5. World Health Organization: International Classification of Diseases edn 10. Geneva: WHO; 1992.
6. Ozonoff S, Pennington BF, Rogers SJ: Executive function deficits in high-functioning autistic individuals: relationship to theory of mind. J Child Psychol Psychiatry 1991, 32:1081-1105.
7. Klin A: Asperger syndrome. Child and Adolescent Clinics of North America 1994, 3:131-148.
8. Wing L: The relationship between Asperger's syndrome and Kanner's autism. In Autism and Asperger's Syndrome. Edited by Frith U. Cambridge, UK: Cambridge University Press; 1991:93-122.
9. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, edn 4. Washington, DC: American Psychiatric Association; 1994.
10. Szatmari P, Archer L, Fisman S, Streiner SL, Wilson F: Asperger's syndrome and autism: differences in behavior, cognition, and adaptive functioning. J Am Acad Child Adolesc Psychiatry 1995, 34:1662-1671.
11. Klin A, Volkmar FR, Sparrow SS, Cicchetti DV, Rourke BP: Validity and neuropsychological characterization of Asperger syndrome: convergence with nonverbal learning disabilities syndrome. J Child Psychol Psychiatry 1995, 36:1127-1140. This paper extends associations between right hemisphere learning problems and AS and is the first to link nonverbal learning disorders with AS. It is important for finding measurable differences between HFA and children with AS, but the inclusion criterion of clumsiness for the AS is important to bear in mind.
12. Asperger H: 'Autistic psychopathy' in childhood. In Autism and Asperger's Syndrome. Edited and translated by Frith U. Cambridge, UK: Cambridge University Press; 1991:37-93.
13. Manjiviona J, Prior M: Comparison of Asperger syndrome and high-functioning autistic children on a test of motor impairment. J Autism Dev Disord 1995, 25:23-79.
14. Rapin I, Allen D: Developmental language disorders: nosological considerations. In Neuropsychology of Language Reading and Spelling. Edited by Kirk U, New York: Academic Press. 1983:155-184.
15. Brook SL, Bowler D: Autism by another name? Semantic and pragmatic impairments in children. J Autism Dev Disord 1992, 22:61-81.
16. Bishop D: Autism, Asperger's syndrome, and pragmatic semantic disorder: where are the boundaries? Br J Disord Comm 1989, 24:107-121.
17. Towbin K: Pervasive developmental disorder not otherwise specified. In The Handbook of Autism and Pervasive Developmental Disorders, edn 2. Edited by Volkmar FR, Cohen DJ. New York: J. Wiley and Sons; 1997, in press.
18. Shields J, Varley R, Broks P, Simpson A: Social cognition in developmental language disorders and high-level autism. Dev Med Child Neurol 1996, 38:487-495. This careful study adds significant support to the claim that SPD and AS may be indistinguishable.
19. Shields J, Varley R, Broks P, Simpson A: Hemispheric function in developmental language disorders and high level autism. Dev Med Child Neurol 1996, 38:473-486.
20. DiLavore PC, Lord C, Rutter M: The pre-linguistic autism diagnostic observation schedule. J Autism Dev Disord 1995, 25:355-381.
21. Lord C, Rutter M, LeCouteur A: Autism Diagnostic Interview-Revised: a revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders. J Autism Dev Disord 1994, 24:659-686.
22. Lord C, Rutter M, Goode S, Heemsbergen J, Jordan J, Mawhood L, Schopler E: Autism diagnostic observation schedule: a standardized observation of communication and social behavior. J Autism Dev Disord 1989 19:185-212.
23. Folstein S, Rutter M: Infantile autism: a genetic study of 21 twin pairs. J Child Psychol Psychiatry 1977, 18:297-321.
24. Bailey A, LeCouteur A, Gottesman I, Bolton P, Simonoff E, Yazuda E, Rutter M: Autism as a strongly genetic disorder: evidence from a British twin study. Psychol Med 1995, 25:63-78.
25. Daniels WW, Warren RP, Odell JD, Maciulis A, Burger RA, Warren WL, Torres AR: Increased frequency of the extended or ancestral haplotype B44-SC30-DR4 in autism. Neuropsychobiology, 1995, 32:120-123. Although the methods for diagnosis were weak, this study is an important step in furthering data on the theory of a genetic susceptibility that is precipitated by a postinfectious event. B44-SC30-DR4 on chromosome 6 is believed to influence major histocompatibility complex, particularly the C4B gene that codes for components of complement.
26. Warren RP, Odell JD, Warren L, Burger RA, Maciulis A, Daniels WW, Torres AR: Strong association of the third hypervariable region of HLA-DR-beta 1 with autism. J Neuroimmunol 1996, 67:97-102.
27. Herault J, Petit E, Marineua J, Perrot A, Lenoir P, Cherpi C, Barthelemy C, Sauvage D, Mallet J, Muh JP, Lelord G: Autism and genetics: clinical approach and association with two markers of HRAS gene. Am J Med Genet 1995, 60:276-281. The c-Harvey-ras (HRAS) oncogene marker on chromosome 11 is interesting because it may be linked to dopamine receptor genes, and HRAS itself appears to produce a factor that influences nerve growth and differentiation. Distribution of specific HRAS alleles was statistically greater in autistic subjects compared with normal controls, but all alleles surfaced in both groups and did not correlate with clinical status.
28. Steffenburg S, Gillberg CL, Steffenburg U, Kyllerman M: Autism in Angelman syndrome: a population based study. Pediatr Neurol 1996, 14:131-136.
29. Flejter WL, Bennett Baker PE, Ghaziuddin M, McDonald M, Sheldon S, Gorski JL: Cytogenetic and molecular analysis of inv dup(15) chromosomes observed in two patients with autistic disorder and mental retardation. Am J Med Genet 1966, 61:182-187.
30. Hotopf M, Bolton P: A case of autism associated with partial tetrasomy 15. J Autism Dev Disord 1995, 25:41-50.
31. Hallmayer J, Spiker D, Lotspeich L, McMahon WM, Petersen PB, Nicholas P, Pingree C, Ciaranello RD: Male to male transmission in extended pedigrees with multiple cases of autism. Am J Med Genet 1996 67:13-18. This important study followed a molecular genetic study that strongly suggested a smaller role for fragile X in the etiology of autism. The current study went on to confirm the previous findings using a different method in order to capture milder forms of the disorder in multiplex pedigrees. The results confirmed that X linkage could not explain a majority of the cases, and fragile X defects were not present in the families in whom X linkage was suspected.
32. Bailey A, Phillips W, Rutter M: Autism: towards an integration of clinical genetic, neuropsychological, and neurobiological perspectives. J Child Psychol Psychiatry 1996, 37:89-126. This lengthy review offers a thorough review of autism research findings in these fields. Detailed discussions of the limitations in methods and recommendations for future investigations are provided. Unusual effort was made to integrate findings across fields in relationship to theory; this one is exceptionally thoughtful.
33. Akefeldt A, Gillberg C, Larsson C: Prader-Willi syndrome in a Swedish rural county: epidemiological aspects. Dev Med Child Neurol 1991, 33:715-721.
34. Pennington BF, Ozonoff S: Executive functions and developmental psychopathology. J Child Psychol Psychiatry 1996, 37:51-87. This is a detailed and scholarly overview of executive function and executive dysfunction in attention deficit hyperactivity disorder, Tourette's syndrome, conduct disorder, and autism. It advances the idea that executive function deficits may predispose to theory of mind deficits and explain other symptoms of autism. It also emphasizes that these deficits are not specific to autism.
35. Shulman C, Yirmiya N, Greenbaum CW: From categorization to classification: a comparison among individuals with autism, mental retardation, and normal development. J Abnorm Psychol 1995, 104:601-609.
36. Swettenham J: Can children with autism be taught to understand false belief using computers? J Child Psychol Psychiatry 1996, 37:157-165. This is a thoughtful, succinct study with provocative results. It makes an important contribution to our knowledge of how ordinary and retarded children (as well as in those with autistic spectrum disorders) acquire false belief skills. Whether children with autism spectrum disorders have difficulties generalizing any experience or only theory of mind remains an open question. It is still uncertain whether learning theory of mind skills advances social competence.
37. Hughes C: Control of action and thought: normal development and dysfunction in autism. A research note. J Child Psychol Psychiatry 1996, 37:229-236.
38. Ozonoff S, Miller JN: An exploration of right hemisphere contributions of the pragmatic impairments of autism. Brain Lang 1996, 52:411-434. At one level this is a replication study, but it goes farther in its comparison of right hemisphere-damaged adults and autistic persons. This well-designed study explores the role of right hemisphere functions in pragmatic language disorder and suggests that parts of executive function may reside in the right hemisphere instead of the frontal lobes, as has been proposed.
39. Dissanayke C, Crossley SA: Proximity and sociable behaviors in autism: evidence for attachment. J Child Psychol Psychiatry 1996, 37:149-156. This methodologically tight study makes a strong claim for distinguishing between reciprocity and attachment in autistic individuals. The clinical relevance is that autistic youngsters display attachment; this finding should not lead clinicians to exclude autism on the presence of these behaviors.
40. Hashimoto T, Tayama M, Murakawa K, Yoshimoto T, Miyazaki M, Harada M, Kuroda Y: Development of the brainstem and cerebellum in autistic patients. J Autism Dev Disord 1995, 25:1-19.
41. McKelvey JR, Lambert R, Mottron L, Shevell MI: Right hemisphere dysfunction in Asperger's syndrome. J Child Neurol 1995, 10:310-314.
42. Chiron C, Leboyer M, Leon F, Jambaque I, Nuttin C, Syrota A: SPECT of the brain in childhood autism: evidence for a lack of normal hemispheric symmetry. Dev Med Child Neurol 1995, 37:849-860.
43. Zilbovicius M, Garrear B, Samson Y, Remy P, Barthelemy C, Syrota A, Lelord G: Delayed maturation of the frontal cortex in childhood autism. Am J Psychiatry 1995, 152:248-252.
44. Dawson G, Klinger LG, Panagiotides H, Lewy, Castelloe P: Subgroups of autistic children based on social behavior display distinct patterns of brain activity. J Abnorm Child Psychol 1995, 23:569-583.
45. Campbell M, Anderson LT, Small AM, Adams P, Gonzalez NM, Ernst M: Naltrexone in autistic children: behavioral symptoms and attentional learning. J Am Acad Child Adolesc Psychiatry 1993, 32:1283-1291.
46. Bouvard MP, Leboyer M, Launay JM, Recasens C, Plumet MH, Waller-Perotte D, Tabuteau F, Bondou D, Dugas M, Lensing P, Panksepp J: Lowdose naltrexone effects on plasma chemistries and clinical symptoms in autism: a double-blind, placebo controlled study. Psychiatry Res 1995, 58:191-201.
47. Willemsen-Swinkels SHN, Buitetlaar JK, Weijnen FG, van Engeland H: Placebo-controlled acute dosage naltrexone study in young autistic children. Psychiatry Res 1995, 58:203-215.
48. Cook EH, Leventhal BL: Autistic and other pervasive developmental disorders. Child and Adolescent Psychiatry Clinics of North America 1995, 4:381-400.
49. Hellings JA, Kelley LA, Garielli WF, Kilgore E, Priti S: Sertraline response in adults with mental retardation and autistic disorder. J Clin Psychiatry 1995, 57:333-336.
50. Quintana H, Birmaher B, Stedge D, Lennon S, Freed J, Bridge J, Greenhill L: Use of methylphenidate in treatment of children with autistic disorder. J Autism Dev Disord 1995, 25:283-295.
51. Armenteros JL, Adams PB, Campbell M, Eisenberg ZW: Haloperidol-related dyskinesias and pre- and perinatal complications in autistic children. Psychopharmacol Bull 1995, 31:363-369. This is a useful analysis of a large number of children followed up by an experienced group of investigators. Tardive or withdrawal dyskinesia occurred in children with and without perinatal complications, but the risk was significantly greater in those with perinatal complications. The implication is that perinatal and delivery histories, including the type of anesthesia used, may influence the preference of pharmacologic agents, closeness of monitoring, doses used, and duration of treatment in order to avoid development of tardive or withdrawal dyskinesia.